Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Amneal Pharmaceuticals, Inc. | SVP, Chief Legal Officer | Performance-Based Restricted Stock Units | 287K | $1.57M | $5.47 | Mar 4, 2024 | Direct |
Amneal Pharmaceuticals, Inc. | SVP, Chief Legal Officer | Restricted Stock Units | 144K | $785K | $5.47 | Mar 4, 2024 | Direct |
Amneal Pharmaceuticals, Inc. | SVP, Chief Legal Officer | Class A Common Stock | 57.3K | $314K | $5.47 | Mar 3, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AMRX | Amneal Pharmaceuticals, Inc. | Mar 3, 2024 | 8 | -$98.6K | 4 | Mar 5, 2024 | SVP, Chief Legal Officer |
AMRX | Amneal Pharmaceuticals, Inc. | Mar 3, 2023 | 5 | -$15.7K | 4 | Mar 7, 2023 | SVP, Chief Legal Officer |
AMRX | Amneal Pharmaceuticals, Inc. | Mar 3, 2022 | 2 | $0 | 4 | Mar 3, 2022 | SVP, Chief Legal Officer |
AMRX | Amneal Pharmaceuticals, Inc. | Jan 17, 2022 | 0 | $0 | 3 | Jan 26, 2022 | SVP, Chief Legal Officer |